Back to Journals » OncoTargets and Therapy » Volume 10

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Total article views   HTML views PDF downloads Totals
18,222 Dovepress* 13,127+ 2,120 15,247
PubMed Central* 5,095 1,307 6,402
Totals 18,222 3,427 21,649
*Since 6 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed and Google Scholar